Status:
COMPLETED
Use of Cidofovir for Recurrent Respiratory Papillomatosis
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Recurrent Respiratory Papillomatosis
Eligibility:
All Genders
5+ years
Phase:
PHASE4
Brief Summary
Recurrent respiratory papillomatosis (RRP) is the most common benign neoplasm of the larynx in the pediatric population. The impact of the disease on patients and families can be tremendous due to the...
Detailed Description
The focus of the present study is to evaluate the usefulness of cidofovir injection in diminishing the frequency and magnitude of papilloma recurrences in adult and pediatric RRP patients. Briefly, pa...
Eligibility Criteria
Inclusion
- 4 surgeries for RRP in last 12 months
Exclusion
- Renal insufficiency
- Nephrotoxic drugs in the last 7 days
- Sulfa allergies
- Currently treated with systemic or topical HPV chemotherapeutic agents
- Females of childbearing potential with a positive pregnancy test
- Women who are breast feeding
Key Trial Info
Start Date :
November 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00205374
Start Date
November 1 1999
End Date
December 1 2009
Last Update
February 26 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.